Toggle navigation
Home
Search
Services
Blog
Contact
About
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
Vaxgen Inc.
Search grants from Vaxgen Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Chloride Channel Regulation in Cystic Fibrosis
Core - Hybridoma
Optical Analysis and Imaging of Single-Walled Carbon Nanotubes
Where Have We Come From and Where Are We Going? Learning the Lessons and Disseminating Exemplary Practices from the Projects of the NSDL
Presidential Award for Excellence in Science and Mathematics Teaching
Recently added grants:
Mechanisms of Staphylococcus aureus and Pseudomonas aeruginosa Co-existence in CF
Development of a semi-quantitative ligation-based assay for Hepatitis B
Small molecule inhibitors of lytic transglycosylase to potentiate beta-lactam antibiotics
How Hepatitis C Virus Regulates Desmosterol to Affect RNA Replication: a New Virus-Host Interaction
Mechanisms of ESX-1-dependent Gene Expression in Pathogenic Mycobacteria
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030053-009
Application #
7329529
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Vaxgen Inc.
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
/ Vaxgen Inc.
NIH 2005
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
/ Vaxgen Inc.
NIH 2004
N01 AI
Production and Testing of rPA Vaccine-26630053
/ Vaxgen Inc.
NIH 2003
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen Vacci-
/ Vaxgen Inc.
Publications
Omland, Kristian S; Brys, April; Lansky, David et al.
(2008)
Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species.
Clin Vaccine Immunol 15:946-53
Comments
Be the first to comment on this grant
